Intron Biotechnology, Inc.

Samsung Electronics Co., Ltd.

Sk Innovation Co., Ltd.

Amkor Technology, Inc.

Samsung Sds Co., Ltd.

Sk Global Chemical Co., Ltd.

International Business Machines Corporation

Amkor Technology Singapore Holding Pte. Ltd.

Sk Energy Co., Ltd.

Korea Institute of Science and Technology

Dreambiogen Co., Ltd.

Intron Blotechnology, Inc.

SAng Hyeon Kang

Seong Jun Yoon

Soo Youn Jun

Jee Soo Son

Hyoun Rok Paik

An Sung Kwon

Soon Hye Hwang

Hee Jeong Shin

Hyoung Rok Paik

In Hwang Kim

Byung Wook Kim

Won Bae Bang

Myung Ahn Ok

Hyun Min Song

Tae Ho Kim

Seung Woo Lee

Byong Jin Kim

Seok Ha Hong

Cheol Jin Kim

Yun Ic Hwang

Pung Yeun Cho

Yu Jeub Ha

Sung Kwang Kim

Kyoung Ho Kim

Gi Mo Jung

Sung Soo Park

Kyu Sang Lee

Jong Sok Hahn

Sung Seok Chae

Kil Hong Lee

Hyun Jin Yu

Taek Kyu Han

Jae Ho Jung

Hyun Joo Im

Suk Hwang Park

Eun Kyoung Oh

Ji Hyun Kim

Beom Seok Kim

Ki Woon Sung

Chang Suk Yoon

Tae Woo Woo

Chang Woo Min

Jeong In Cha

Saet Byeol Kim

Jung In Pyo

Seong Mook Kim

Jeong Won Park

Dong Min Kang

Geun Woo Lee

Sung Kwan Kim

Jin Hee Lee

Sang Won Lee

Hoon Sik Kim

Jong Hyun Kim

Jong Jin Lee

Ho Seong Lee

Jong Min Baek

Dong Joo Park

Ju Young Lee

Jae Yun Kim

Jin Young Khim

Doo-Hwan Park

Yong Soo Kang

Eui Bok Lee

Shaun Bowers

Jun Tae Kim

Byung Hee Kim

Kookheon Char

Sang Hoon Ahn

Woo Kyung You

Rak Hwan Kim

Gi Tae Lim

Gyu Wan Han

Min Hwa Chang

Kil Young Lee

Se Hwan Hong

Dae Ho Shin

Won Bin Kim

Deok Young Jung

Jong Hak Kim

Ji Young Park

Seung Woo Cho

Jung Min Kim

Myung Jea Choi

Sang Kil Lee

Hyeok Sang Oh

Byoung Woo Cho

Taek Chan Kang

Jongok Won

Tae-Jin Kim

Chong Su Cho

Young Woon Kwon

Han Saem Seo

Eun Ji Jung

Seung Jae Yu

Sang Ji Bae

In Kyu Park

Seul Bee Lee

Sung-Kwan Kim

Kyung Rok Park

An antibacterial protein againstwith the amino acid sequence as set forth in SEQ ID NO: 1 is disclosed. Also disclosed is a method of preparing an antibacterial protein against. The method includes: culturing BL21-pBAD-BAL200 cells, the BL21-pBAD-BAL200 cells including a plasmid that comprising a sequence as set forth in SEQ ID NO: 2; inducing the expression of the antibacterial protein; and purifying the antibacterial protein.

Antibacterial protein having lytic activity togenus and method for preparing the same

A composition for preventing or treating an infection or disease caused by enterotoxigenicincludes a Siphoviridae bacteriophage (Bac-FRP-5) having an ability to lyse the enterotoxigeniccells and a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by enterotoxigenicincludes administering to a subject a Siphoviridae bacteriophage and lysing the enterotoxigeniccells by the Siphoviridae bacteriophage.

Compositions and methods for inhibiting the proliferation of enterotoxigenic

A composition for preventing or treating an infection or disease caused by enterotoxigenicincludes a Siphoviridae bacteriophage (Bac-FRP-4) having an ability to lyse the enterotoxigeniccells and a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by enterotoxigenicincludes administering to a subject a Siphoviridae bacteriophage and lysing the enterotoxigeniccells by the Siphoviridae bacteriophage.

Compositions and methods for inhibiting the proliferation of enterotoxigenic bacteroides fragilis

A composition for preventing or treating an infection or disease caused by enterotoxigenicincludes a Siphoviridae bacteriophage (Bac-FRP-3) having an ability to lyse the enterotoxigeniccells and a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by enterotoxigenicincludes administering to a subject a Siphoviridae bacteriophage and lysing the enterotoxigeniccells by the Siphoviridae bacteriophage.

The present invention relates to abacteriophage STP-2 (Accession number: KCTC 12853BP) isolated from nature and characterized by having the ability to destroyand having a genome represented by SEQ ID NO:1; and to a method for preventing and treating diseases caused byusingbacteriophage STP-2 containing the same as an active ingredient.

bacteriophage STP-2 and use thereof for inhibiting proliferation of

The present invention relates to an intracellular expression enhancing genetic element, which enhances the intracellular expression of target protein encoded in RNA therapeutics such as mRNA vaccines and RNA medicines. In more detail, the present invention relates to the RNA molecule which has the genetic element capable of enhancing the intracellular expression of target protein encoded in RNA therapeutics delivered into cells; the plasmid used to synthesize the RNA molecule having the genetic element 'E3'; the method for synthesizing RNA molecule having the genetic element “E3” using the plasmid and utilizing the synthesized RNA molecule as RNA therapeutics.

Genetic element E3 for enhanced intracellular expression of target protein encoded in RNA therapeutics

The present invention relates to a Myoviridae bacteriophage Aer-HYP-3 (Accession number: KCTC 13479BP) isolated from nature, which has the ability to killbacteria and has the genome represented by SEQ ID NO: 1, and to a method of preventing and treating a disease caused bybacteria using a composition containing the same as an active ingredient.

bacteriophage Aer-HYP-3 and use thereof for inhibiting growth ofbacteria

A composition for preventing or treating an infection or disease caused by a pathogenicincludes a Podoviridae bacteriophage (Esc-COP-30) having an ability to lyse the pathogenicand a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by a pathogenicincludes administering to a subject a Podoviridae bacteriophage and lysing the pathogenicby the Podoviridae bacteriophage.

Compositions and methods for inhibiting the proliferation of pathogenic

The present invention relates to a Myoviridae bacteriophage Vib-PAP-7 (Accession number: KCTC 13247BP) isolated from nature, which has the ability to killand has the genome represented by SEQ ID NO: 1, and a method for preventing or treating a disease caused byusing a composition containing the Myoviridae bacteriophage Vib-PAP-7 as an active ingredient.

Vibrio parahaemolyticus bacteriophage Vib-PAP-7 and use of same for inhibiting vibrio parahaemolyticus bacteria proliferation

The present invention relates tobacteriophage Vib-PAP-4(Accession No. KCTC 13168BP), isolated from nature, which possesses ability to specifically killbacteria and has the genome represented by SEQ ID No: 1, and a method for preventing infection ofbacteria and treating infection ofbaceteria, using a composition containing the bacteriophage as an effective ingredient.

bacteriophage Vib-PAP-4 and use thereof in inhibiting proliferation ofbacteria

A composition for preventing or treating an infection or disease caused by a pathogenicincludes a Myoviridae bacteriophage Esc-COP-18 having an ability to lyse the pathogenicand a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by a pathogenicincludes administering to a subject a Myoviridae bacteriophage and lysing the pathogenicby the Myoviridae bacteriophage.

A composition for preventing or treating an infection or disease caused by a pathogenicincludes a Myoviridae bacteriophage having an ability to lyse the pathogenicand a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by a pathogenicincludes administering to a subject a Myoviridae bacteriophage and lysing the pathogenicby the Myoviridae bacteriophage.

Provided are a method for fabricating a semiconductor package and a semiconductor package using the same, which can simplify a fabricating process of the semiconductor package by forming a lead frame on which a semiconductor die can be mounted without a separate grinding process, and can improve product reliability by preventing warpage from occurring during a grinding process. In one embodiment, the method for fabricating a semiconductor package includes forming a frame on a carrier, forming a first pattern layer on the frame, first encapsulating the frame and the first pattern layer using a first encapsulant, forming conductive vias electrically connected to the first pattern layer while passing through the first encapsulant, forming a second pattern layer electrically connected to the conductive vias on the first encapsulant, forming a first solder mask formed on the first encapsulant and exposing a portion of the second pattern layer to the outside, removing the frame by an etching process and etching a portion of the first pattern layer, and attaching a semiconductor die to the first pattern layer.

Method for fabricating semiconductor package and semiconductor package using the same

A pharmaceutical composition for treating Gram negative bacteria-associated infections includes an antibacterial protein that includes at least one selected from the group consisting of a protein having the amino acid sequence as set forth in SEQ ID NO: 1, a protein having the amino acid sequence as set forth in SEQ ID NO: 2, a protein having the amino acid sequence as set forth in SEQ ID NO: 3, a protein having the amino acid sequence as set forth in SEQ ID NO: 4, a protein having the amino acid sequence as set forth in SEQ ID NO: 5, a protein having the amino acid sequence as set forth in SEQ ID NO: 6, a protein having the amino acid sequence as set forth in SEQ ID NO: 7, and a protein having the amino acid sequence as set forth in SEQ ID NO: 8. A method of preparing the antibacterial protein is also disclosed.

Antibacterial composition effective in treating gram negative bacterial infections and method for preparing the same

A method for batch processing for a plurality of individual transactions includes generating a batch transaction by aggregating at least some of the plurality of individual transactions according to a setting value of a batch size, and processing the batch transaction via a blockchain network. The generation of the batch transaction includes adjusting the setting value of the batch size based on a monitoring result for a transaction processing status, and generating the batch transaction according to the adjusted setting value.

Apparatus and method for batch processing for blockchain transactions

Growing community of inventors

Seoul, South Korea

SAng Hyeon Kang